Neuroimmunology in Clinical Practice - part 4 pot

Neuroimmunology in Clinical Practice - part 4 pot

Neuroimmunology in Clinical Practice - part 4 pot

... 1993. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology, 43 (4) , 655–61. The ... Progressive Efficacy Clinical Trial of Recombinant Interferon-beta-1a in MS (SPECTRIMS) Study Group. 2001. Randomized controlled trial of interferon-beta-1a in secondary progres...

Ngày tải lên: 10/08/2014, 00:20

27 483 0
Neuroimmunology in Clinical Practice - part 5 potx

Neuroimmunology in Clinical Practice - part 5 potx

... Suzuki, N., Shimizu, N. et al. 1993. Involvement of cytokines in N-methyl-N’-nitro-N- nitrosoguanidine-induced plasminogen activator activity in acute disseminated encephalomyelitis and multiple ... identified. Inter- leukin 23 (IL-23) may play an important role in the early effector phase of immune-mediated peripheral nerve demyelination in EAN, as well as in human GBS. IL-23 is hig...

Ngày tải lên: 10/08/2014, 00:20

27 432 0
Neuroimmunology in Clinical Practice - part 9 pot

Neuroimmunology in Clinical Practice - part 9 pot

... solution using the same manufacturing method was licensed in 1992. Solvent detergent treatment, including partitioning steps and incubation at low pH in the final container has been effective in the ... and exten- sion into the brain involving veins and arteries of varying caliber. The clinicopathological syndrome was delineated and so named for the distinctive pathology (Cravioto and Fe...

Ngày tải lên: 10/08/2014, 00:20

27 398 0
Chapter 064. The Practice of Genetics in Clinical Medicine (Part 4) potx

Chapter 064. The Practice of Genetics in Clinical Medicine (Part 4) potx

... that, for the majority of adult-onset, multifactorial genetic Chapter 0 64. The Practice of Genetics in Clinical Medicine (Part 4) Figure 6 4- 2 disorders, testing is purely predictive. Test ... disorder. In addition to molecular testing for established disease, genetic testing for susceptibility to chronic disease is being increasingly integrated into the practice of m...

Ngày tải lên: 07/07/2014, 01:20

5 429 0
Chapter 067. Applications of Stem Cell Biology in Clinical Medicine (Part 4) pot

Chapter 067. Applications of Stem Cell Biology in Clinical Medicine (Part 4) pot

... Biology in Clinical Medicine (Part 4) Other Organ Systems and the Future The use of stem cells in regenerative medicine has been studied for many other organ systems and cell types, including ... revolution in therapeutics- recent advances in stem cell biology and thei r therapeutic applications in regenerative medicine and cancer therapies. Clin Pharmacol Ther 82(3):25...

Ngày tải lên: 07/07/2014, 01:20

5 311 0
Neuroimmunology in Clinical Practice - part 1 ppt

Neuroimmunology in Clinical Practice - part 1 ppt

... cm. Includes bibliographical references and index. ISBN-13: 97 8-1 -4 0 5 1-5 84 0 -4 (hardback : alk. paper) ISBN-10: 1 -4 05 1-5 84 0-9 (hardback : alk. paper) 1. Neuroimmunology. 2. Nervous system—Diseases—Immunological ... that are incor- porated into compact myelin. Interestingly, one of the MOBP isoforms (MOBP155) includes tandem repeats of a proline-rich domain, suggestin...

Ngày tải lên: 10/08/2014, 00:20

27 417 0
Neuroimmunology in Clinical Practice - part 2 pdf

Neuroimmunology in Clinical Practice - part 2 pdf

... HLA-B HLA-C HLA-X HLA-E HLA-H HLA-A HLA-F HLA-G MOG αβ 21-OH C4 BFC2 2000 3000 40 00 Telomere kb Fig. 3.1 The figure depicts the MHC class II, class III, and class I regions encompassing 4 MB in ... enhancing MRI lesions. Chemokines form a chemo-attractant gradient that is perceived by T cells and assists their invasion into the CNS. Chemokines, including interferon γ-inducible protein-10...

Ngày tải lên: 10/08/2014, 00:20

27 462 0
Neuroimmunology in Clinical Practice - part 3 pdf

Neuroimmunology in Clinical Practice - part 3 pdf

... anti-CD40L/-CD1 54 (IDEC-131); anti-IL-12, anti-CD6; anti-CD3 (OKT3); anti-Vβ5.2/5.3 + T cells; anti-CD4; integrin inhibitors Lymphocyte-specific cytoplasmic protein – tyrosine kinase P56lck; zeta-associated protein ... 25-year-old male with secondary-progressive MS (a, b, c) showing homogeneously enhancing lesions (a) and from a 29-year-old female with relapsing-remitting MS (d, e, f ) showi...

Ngày tải lên: 10/08/2014, 00:20

27 436 0
Neuroimmunology in Clinical Practice - part 6 pdf

Neuroimmunology in Clinical Practice - part 6 pdf

... consistent benefit include indomethacin, somatostatin analogs, caffeine, ergot alkaloids, and nocturnal desmopressin. L-threo-3, 4- dihydroxyphenylserine is used in the rare but dis- tinctive entity, ... G. 1996. Chronic in ammatory demy- elinating polyneuropathy (CIDP) in diabetics. J Neurol Sci, 142 , 59– 64. Sumner, A.J. 19 94. Electrophysiology of the in am- matory demyelinating p...

Ngày tải lên: 10/08/2014, 00:20

27 356 0
Neuroimmunology in Clinical Practice - part 7 pps

Neuroimmunology in Clinical Practice - part 7 pps

... 1 64 Neuro-Sjögren’s syndrome 183 and activation of the in ltrating, predominantly CD4 lymphocytes. The presented antigens include SSA (Ro), SSB (La), α-fodrin, β-fodrin, and muscarinic cholinergic ... Griggs, 20 04) . Thus screening for immunocytochemical staining for proteins known to be associated with muscular dystrophies is appropriate. The main finding in DM is perivascular B-cell-pr...

Ngày tải lên: 10/08/2014, 00:20

27 348 0
w